Girls in Colombian town struck by mystery illness

August 28, 2014 by Joshua Goodman

A mystery illness has overwhelmed a small town in northern Colombia as scores of teenage girls have been hospitalized with symptoms that parents fear could be an adverse reaction to a popular vaccine against cervical cancer.

Authorities say they still don't know what caused more than 200 girls in El Carmen de Bolivar to come down with symptoms ranging from fainting to numbness in the hands and headaches. Some have hinted that the town of 95,000 near Colombia's Caribbean coast could be experiencing a rare case of .

Parents are on edge however because all the girls, ranging in ages from 9 to 16, were injected in recent months with the Gardasil. On Wednesday, residents marched peacefully to demand a thorough investigation.

Francisco Vega, the town's mayor and a trained physician, told The Associated Press that illnesses first appeared at the end of May and have been steadily increasing since. Over the weekend 120 were rushed to hospitals, collapsing the town's limited medical facilities. None of their symptoms were life-threatening and all have since been released, he said.

Echoing the assurances of national health and toxicology experts, who have traveled to the town to collect blood samples and investigate possible environmental hazards, he said there's no evidence the vaccine, which has undergone extensive testing and regulation globally, is to blame.

Meanwhile, Health Minister Alejandro Gaviria is criticizing hyped coverage by the media for stirring panic, saying concerns about their vaccine, which has been applied to 2.9 million women in Colombia, are baseless.

"On one side we have the weight of scientific evidence and on the other are opinions and moral prejudices," he told W Radio on Wednesday, adding the claims the lives of more than 3,000 women every year in Colombia.

Veronica Trulin, head of communications in Latin America for Merck, said all lots of the vaccine, including the ones sent to Colombia, meet all required quality and safety standards.

"We don't comment on speculation about our products," she said in an email.

Explore further: Early evidence of HPV vaccine impact

Related Stories

Early evidence of HPV vaccine impact

June 20, 2011

( -- In a new study published in Lancet, researchers from Australia report evidence that the vaccine designed to target the human papillomavirus, or HPV, has dramatically dropped the incidence of lesions in Australian ...

Report: Teen HPV vaccination rate still lagging

July 25, 2013

(AP)—Disappointed health officials say only about half of teenage girls have gotten a controversial vaccine against cervical cancer—a rate that's changed little in three years.

1 in 5 boys got HPV shot in first year recommended

August 29, 2013

A new report offers a first look at how many boys are getting shots designed to protect girls from cervical cancer. Health officials say the number getting vaccinated so far is a good start.

Three doses of HPV vaccine recommended against genital warts

February 11, 2014

Two doses of vaccine against human papillomavirus (HPV) provide good protection against genital warts, but three doses is better according to an extensive register study by researchers at Karolinska Institutet in Sweden. ...

Recommended for you

Monkeys in Asia harbor virus from humans, other species

November 19, 2015

When it comes to spreading viruses, bats are thought to be among the worst. Now a new study of nearly 900 nonhuman primates in Bangladesh and Cambodia shows that macaques harbor more diverse astroviruses, which can cause ...

One-step test for hepatitis C virus infection developed

November 14, 2015

UC Irvine Health researchers have developed a cost-effective one-step test that screens, detects and confirms hepatitis C virus (HCV) infections. Dr. Ke-Qin Hu, director of hepatology services, will present findings at the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.